Recruiting NA Gestational Diabetes Mellitus

New treatment option for Gestational Diabetes Mellitus

Official title Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)

ClinicalTrials.gov ID: NCT07158970

What this study is testing

What it's testing
This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 51, women only

You may be able to join if

  • Singleton pregnancy
  • GDM diagnosed by OGTT or glucose monitoring
  • Hebrew speaking
  • Compatible cellphone

You likely can't join if

  • Pregestational diabetes
  • Fetal anomalies/genetic abnormalities
  • Multifetal pregnancy
  • Late GDM diagnosis (after 34 weeks)

The study team makes the final eligibility decision.

Where it's taking place

  • H̱olon, Central District, Israel

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years to 51 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include H̱olon, Central District, Israel. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.